Opus Genetics partners with the Global RDH12 Alliance to advance gene therapy for inherited retinal disease, aiming for FDA ...

EyePoint Pharmaceuticals completes enrollment for the LUCIA trial, advancing DURAVYU's potential as a new treatment for wet ...

Justis Ehlers, MD, FASRS, a retina surgeon from the Cole Eye Institute at the Cleveland Clinic presented at the 2025 annual meeting of the American Society of Retina Specialists (ASRS). The meeting ...

Genentech reveals five-year data showing Susvimo effectively maintains vision in wet AMD patients with fewer injections, offering a promising treatment alternative.

Retina Surgeon, Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio ...

Nimesh A. Patel, MD, FASRS, from Mass Eye and Ear Hospital and Boston Children's Hospital presented a real-world study using the Vestrum database to examine usage trends for pegcetacoplan and ...

At the 2025 American Society of Retina Specialists (ASRS) meeting in Long Beach, California, Yasha S. Modi, MD, associate professor of ophthalmology at NYU Langone, presented end-of-study results from ...

Steven D. Ness, MD, an attending physician at the VA Boston Healthcare System and assistant professor at Boston University, presented a study examining the relationship between vitamin D levels and ...

Newsletter Keep your retina practice on the forefront—subscribe for expert analysis and emerging trends in retinal disease management.

Christina Weng, MD, MBA, FASRS, explores the viability of postoperative day 0 exams as a substitute for day 1 after vitreoretinal surgery, revealing promising findings.